EP

Epi Biotech Co., Ltd.

Developing alopecia therapies, skin regeneration products, and preclinical CRO services.

446440 | KO

Overview

Corporate Details

ISIN(s):
KR7446440000
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 엠동 1903호(송도동, 송도테크노파크아이티센터), 인천광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Epi Biotech Co., Ltd. is an advanced biopharmaceutical company specializing in the research and development of treatments for alopecia (hair loss). The company focuses on developing a pipeline of innovative cell and antibody therapies to meet the demand for hair restoration. It also provides preclinical Contract Research Organization (CRO) services for hair loss studies. Additionally, Epi Biotech conducts R&D in skin regeneration treatments with the goal of creating commercially viable consumer products. The company leverages what it describes as South Korea's largest alopecia genomic database to support its research efforts.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-31 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 8.2 KB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 20.6 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 12.9 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 71.6 KB
2025-06-24 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.1 KB
2025-06-24 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-05-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 168.9 KB
2025-04-24 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.1 KB
2025-04-16 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 51.4 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.2 KB
2025-03-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 91.4 KB
2025-03-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.1 KB
2025-03-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제3자배정 유상증자)
Korean 5.1 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 9.8 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 748.3 KB

Automate Your Workflow. Get a real-time feed of all Epi Biotech Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Epi Biotech Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Epi Biotech Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alkaloid AD Logo
Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.
North Macedonia
ALK
Alkermes plc. Logo
Develops medicines for CNS disorders like schizophrenia, bipolar, and sleep disorders.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
Develops personalized cancer drugs using a diagnostic platform to predict patient response.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom
AGY
Alligator Bioscience Logo
Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Developing off-the-shelf CAR T-cell therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain
ALM
ALNYLAM PHARMACEUTICALS, INC. Logo
Pioneering RNAi gene-silencing therapies for rare genetic and cardiometabolic diseases.
United States of America
ALNY
Alpha Cognition Inc. Logo
Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.
United States of America
ACOG

Talk to a Data Expert

Have a question? We'll get back to you promptly.